Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Pre-treatment Patient Characteristics.

More »

Table 1 Expand

Fig 1.

Percent changes of pre-treatment versus SVR24 liver stiffness liver.

The figure shows the median percent change of LS for each METAVIR fibrosis stage stratified by the pre-treatment LS score.

More »

Fig 1 Expand

Fig 2.

Pre-treatment versus SVR24 liver stiffness.

Comparison of pre-treatment to SVR24 LS in kPa stratified by METAVIR fibrosis stage with (A) depicting median and interquartile ranges for pre-treatment scores and (B) depicting median and interquartile ranges for SVR24 scores. The vertical axis is the liver stiffness in kPa and the horizontal axis is the METAVIR fibrosis stage and the number of patients in each fibrosis stage. The top and bottom boxes represent interquartile ranges (interquartile 1 and interquartile 3 respectively). The lines through the boxes represent median values. The whiskers at the end of the box represent the maximum and minimum values.

More »

Fig 2 Expand

Table 2.

Estimated Fibrosis Stage using Fibroscan at SVR24 Stratified by the Pre-treatment Stiffness Score.

More »

Table 2 Expand

Table 3.

Median Change in LS from Pre-treatment to SVR24 Stratified by Pre-treatment Estimated Fibrosis Stage using FibroScan.

More »

Table 3 Expand

Table 4.

Changes in Liver Stiffness (pre-treatment to SVR24): IFN vs IFN-free Regimens.

More »

Table 4 Expand

Table 5.

Comparison of Pre-treatment and SVR24 Clinical Laboratory Values.

More »

Table 5 Expand

Table 6.

Linear Regression Analysis of the Percent Change in Liver Stiffness and the Change in Laboratory Values from Pre-treatment to SVR24.

More »

Table 6 Expand

Fig 3.

Liver stiffness changes during follow-up post-SVR24.

The graph shows FibroScan scores in 56 patients who had an additional measurement afterSVR24. 0 on the horizontal axis indicates SVR24. Stiffness decreased over time, but the change was not significant as demonstrated by linear regression with a p-value = 0.9. The colors indicate the pre-treatment fibrosis stage as estimated from the LS score, green (F0-1), yellow (F2), orange (F3), red (F4).

More »

Fig 3 Expand

Fig 4.

Model of changes in liver stiffness overtime.

This model graph shows a percentage decrease in liver stiffness from pre-treatment to post-SVR24. The initial decline in liver stiffness is most likely due to regression of liver inflammation. After SVR24 there was little change in liver stiffness over time as indicated in Fig 3.

More »

Fig 4 Expand